Yahoo Web Search

  1. Fuel Tech, Inc. FTEK is scheduled to report first-quarter 2019 results on May 13, after market close. The Air Pollution Control (“APC”) segment develops advanced proprietary technologies for ...

  2. VKTX: Pre-IND Meeting with FDA in Summer 2019; Phase 2b NASH Trial to Initiate 2H19…

    Zacks Small Cap Research via Yahoo FinanceMay 03 19:00 PM

    Viking Therapeutics, Inc. (VKTX) is currently preparing for the initiation of a Phase 2b clinical trial of VK2809, the company’s thyroid beta receptor (TRβ) agonist, for the treatment of nonalcoholic ...

  3. CECO Environmental (CECE) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceMay 09 14:23 PM

    I would now like to turn the conference over to Matt Eckl, chief financial officer of CECO Environmental. Thank you for joining us on the CECO Environmental first-quarter 2019 conference call ...

  4. MTBC, Inc (MTBC) reported financial results for their first quarter 2019 and provided a business update. As a reminder, financial performance immediately benefitted from the transaction, which ...

  5. OPNT: Encouraging Pharmacokinetic Data for OPNT003…

    Zacks Small Cap Research via Yahoo FinanceMay 13 16:45 PM

    The company recorded a total of $5.4 million in revenue for the three months ending Mar. 31, 2019, which consisted of $3.7 million in royalty revenue from the sale of NARCAN® Nasal Spray, $1.6 ...

  6. DFFN: Phase 2 Study of TSC in Stroke to Start in Summer 2019…

    Zacks Small Cap Research via Yahoo FinanceMay 13 18:45 PM

    Diffusion Pharmaceuticals, Inc. (DFFN) is currently planning to conduct the Pre-Hospital Ambulance Stroke Trial – TSC (PHAST-T), which will be a randomized, double blind, placebo controlled ...

  7. AZRX: Secondary Endpoint Data Released for MS1819-SD in Chronic Pancreatitis Patients

    Zacks Small Cap Research via Yahoo FinanceMay 23 13:45 PM

    On May 20th AzurRx BioPharma, Inc. (AZRX) presented secondary endpoint results for its Phase II Chronic Pancreatitis (CP) study, which completed clinical work in June 2018. The update follows ...

  8. ABDC: Q1 2019 NAV Improves As Company Explores Strategic Alternatives

    Zacks Small Cap Research via Yahoo FinanceMay 08 13:15 PM

    Alcentra Capital's (ABDC) reported Q1 2019 earnings and again increased NAV. The new management team continues to execute on its strategy of rotating toward a larger middle market, senior secured ...

  9. OIIM: O2Micro Cuts Expenses After a Weak Q1

    Zacks Small Cap Research via Yahoo FinanceMay 06 15:15 PM

    O2Micro (OIIM) revenues for Q1 came in at $12.8 million inline with its downwardly revised guidance of $12.5 million to $13 million. Weakness in TV sales in China continues, but demand has been ...

  10. ORMP: Data from Phase 1 Trial of Oral GLP-1 in 2Q19…

    Zacks Small Cap Research via Yahoo FinanceMay 07 20:15 PM

    Oramed Pharmaceuticals Inc. (ORMP) is a biotechnology company with a proprietary oral protein delivery platform technology. The lead development candidate is ORMD-0801, an oral insulin, that ...

  1. Ads
    related to SCR